Game Creek Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-160,000
Closed -$4.61M 69
2023
Q4
$4.61M Buy
+160,000
New +$4.84M 1.93% 14
2021
Q3
Sell
-70,000
Closed -$2.74M 77
2021
Q2
$2.74M Buy
+70,000
New +$2.72M 1.38% 27
2020
Q3
Sell
-126,480
Closed -$3.92M 62
2020
Q2
$3.92M Buy
+126,480
New +$4.3M 3.22% 14

Other funds holding PFE

Game Creek Capital's PFE Position: Q1 2026 in Review

Game Creek Capital reduced its Pfizer (PFE) stake by 0.37% in Q1 2026, selling an estimated $13.3K and leaving 134,375 shares worth $3.77M. The position accounts for 1.25% of the portfolio, ranked #28.

Game Creek Capital first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $16.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Game Creek Capital held 134,375 shares of Pfizer worth $3.77M as of Q1 2026.
  • Game Creek Capital sold 500 Pfizer shares in Q1 2026, an estimated $13.3K.
  • Pfizer made up 1.25% of Game Creek Capital's portfolio in Q1 2026, its #28 holding.
  • Game Creek Capital first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
  • Game Creek Capital's Pfizer position peaked at $16.1M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Game Creek Capital's 13F filing for Q1 2026, filed 14 May 2026.